pramipexole has been researched along with butaclamol in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (butaclamol) | Trials (butaclamol) | Recent Studies (post-2010) (butaclamol) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 33 | 0 | 8 |
| Protein | Taxonomy | pramipexole (IC50) | butaclamol (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.0123 | |
| D | Rattus norvegicus (Norway rat) | 0.002 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.05 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0139 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0053 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Jiang, C; Keck, TM; Levant, B; Newman, AH; Wang, S | 1 |
1 other study(ies) available for pramipexole and butaclamol
| Article | Year |
|---|---|
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.
Topics: Animals; Arrestins; beta-Arrestins; Cell Line; Cyclobutanes; Humans; Male; Naphthalenes; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine | 2014 |